Bio-HPF CANADA
Natural health product licensed in Canada
- Licence holder
- Biotics Research Corporation
- NPN or DIN-HM
- 80048395
- Status
- Inactive licence
- Licence date
- 14 February 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Pimpinella anisum Source : Graine(s) | 20 mg | Not calculated |
| Réglisse déglycyrrhizinée Source : Glycyrrhiza glabra - racine Extraction ratio : 3:1 Dry plant equivalent : 300 mg | 100 mg | Not calculated |
| Chlorure de 5,6-dihydro-9,10-diméthoxybenzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium Source : Berberine hydrochloride | 40 mg | Not calculated |
| Commiphora myrrha Source : Gum oleoresin | 60 mg | Not calculated |
| Berberis aquifolium Source : Racine | 20 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Eau, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 days |
Uses authorised in Canada
Clove is traditionally used in herbal medicine as a carminative for the relief of digestive complaints such as flatulence or abdominal tension.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are taking prescription medication, consult a health care practitioner prior to use. Consult a health care practitioner if symptoms persist. Consult a health care practitioner if symptoms worsen. Consult a health care practitioner prior to use if you have diabetes or a kidney or urinary tract disorder.
- Contre-indications
Do not take within 90 minutes of other medication. Do not use if you are pregnant or breastfeeding. Ensure adequate fluid intake. If you have difficulty swallowing, do not use. If you have constipation accompanied by severe abdominal pain, nausea, vomiting, or fever, do not use. If you have a liver disorder or gall bladder disease (e.g. gall stones), fever, internal inflammation, a cardiovascular disorder or uterine bleeding, do not use.
Source
Official Health Canada record, licence 80048395
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.